Birkenhäger, T.K.

seizure duration esmolol electroconvulsive therapy fluvoxamine seizure duration plasma effect trial therapy dosage study patient level placebo electroconvulsive labetalol plasma level treatment response agent publication 2007 lippincott williams session nicardipine ratio concentration increase psychiatry heart rate plasma levels pressure predefined plasma level landiolol drug therapy difference william infusion article range lippincott predefined wilkin electrode placement howie variable comparison weight minute risk factors blood administration predefined plasma levels beta-adrenergic diastolic blood pressure reprint randomized kovac plasma concentrations broek ect sessions efficacy 4 weeks hypertensive response urapidil attenuated side effects anesth order anesthesia outcome pharmacokinetic placebo-controlled analg table stimulus alternative 215.0 ng /ml fluvoxamine plasma concentrations beta-blocking